Pharming Names Leverne Marsh, Kenneth Lynard Interim Co-CEOs as Fabrice Chouraqui Steps Down

PUBT · 2d ago
Pharming Names Leverne Marsh, Kenneth Lynard Interim Co-CEOs as Fabrice Chouraqui Steps Down
  • Pharming Group announced September 29, 2026, that Fabrice Chouraqui mutually agreed to step down as CEO and executive director, effective immediately.
  • The board appointed Chief Commercial Officer Leverne Marsh and Chief Financial Officer Kenneth Lynard as interim co-CEOs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharming Group NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610270200PRIMZONEFULLFEED1001280014) on October 27, 2026, and is solely responsible for the information contained therein.